🔎 Trials Near Me

Hjem › Wilms tumor › District of Columbia › Washington

Kliniske studier for Wilms tumor i Washington, DC

7 studier for Wilms tumor søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
Alder 12 til 39 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT04616560

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekruttererFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

RekruttererFase 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
Opp til 30 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04322318

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

RekruttererFase 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Alder 1 til 23 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07172958

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RekruttererFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alle kjønn · Oppdatert 19. mai 2026 · NCT04901702

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

RekruttererFase 2
  • Children's National Hospital (Data Collection Only), Washington D.C.
12 Months · Alle kjønn · Oppdatert 6. mai 2026 · NCT05985161

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Alle kjønn · Oppdatert 12. aug. 2025 · NCT05135975

Wilms tumor-studier i andre byer

Andre studier i Washington

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.